Fair dinkum. We have those that don’t hold the stock back telling others how smart observers they are & how intellectually handicapped everyone else is, which includes sophisticated investors, reputable fund managers and brokers, along with plenty of retail investors who have stuck solid. YES a raising shortfall but still some risk on table and we are living in uncertain times. So the Instos went in and some smaller guys did not. The company flagged next step information within prior announcements, which should provide some material updates in 2nd half CY.
Otherwise a bit of noise from some quarters with commentary from holders that simply reflects the impatient versus the patient. Pretty normal in any investor base as you move from proof of product towards revenue.
I am happy to be in the patient camp and let management get on with it. Good experienced Board and new talent in ranks should reveal good progress next 6 months. Affordable risk right now IMO
OSL Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)